NIRAPARIB for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 293 adverse event reports in the FDA FAERS database where NIRAPARIB was used for Neoplasm malignant.
Most Reported Side Effects for NIRAPARIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Nausea | 5,794 | 26.8% | 182 | 1,368 |
| Fatigue | 5,240 | 24.2% | 146 | 1,181 |
| Constipation | 4,128 | 19.1% | 108 | 984 |
| Platelet count decreased | 4,102 | 19.0% | 124 | 1,186 |
| Insomnia | 2,861 | 13.2% | 57 | 571 |
| Blood pressure increased | 2,464 | 11.4% | 51 | 545 |
| Headache | 2,383 | 11.0% | 38 | 507 |
| Off label use | 2,213 | 10.2% | 114 | 448 |
| Vomiting | 2,029 | 9.4% | 101 | 711 |
| Carbohydrate antigen 125 increased | 1,868 | 8.6% | 44 | 409 |
| Decreased appetite | 1,865 | 8.6% | 101 | 557 |
| Asthenia | 1,862 | 8.6% | 73 | 631 |
| Product dose omission issue | 1,852 | 8.6% | 35 | 443 |
| Haemoglobin decreased | 1,759 | 8.1% | 51 | 522 |
| Dizziness | 1,596 | 7.4% | 33 | 399 |
Other Indications for NIRAPARIB
Ovarian cancer (14,750)
Product used for unknown indication (2,077)
Fallopian tube cancer (1,704)
Malignant peritoneal neoplasm (1,632)
Ovarian cancer recurrent (521)
Ovarian epithelial cancer (457)
Ovarian epithelial cancer recurrent (226)
Endometrial cancer (181)
Genital neoplasm malignant female (158)
Retroperitoneal cancer (145)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)